Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,737,668
-$701,546 QoQ
Shares Held
813,589
-38.3% QoQ
Ownership
0.784%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 210 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. NRIX ranks #112 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in NRIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,737,668 | 813,589 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $20,439,214 | 1,318,659 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,441,559 | 1,077,573 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $5,750,042 | 622,299 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,657,671 | 584,519 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,028,754 | 507,471 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $8,731,755 | 463,469 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $11,532,075 | 513,221 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,694,260 | 464,507 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,242,189 | 492,666 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,909,207 | 281,900 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,857,313 | 363,526 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,223,253 | 322,648 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $4,801,504 | 540,710 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $6,825,694 | 621,648 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $10,750,779 | 825,079 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $4,204,450 | 331,843 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $4,422,480 | 315,666 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,930,698 | 308,487 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $3,736,461 | 124,715 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,451,002 | 280,852 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,791,121 | 347,093 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,245,971 | 159,549 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||